Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aethlon Medical Q2 EPS $(1.22) Beats $(1.40) Estimate

Author: Benzinga Newsdesk | November 14, 2023 05:36pm
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(1.22) per share which beat the analyst consensus estimate of $(1.40) by 12.86 percent. This is a 32.22 percent increase over losses of $(1.80) per share from the same period last year.

Posted In: AEMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist